ISOQUINOLINES AS UROKINASE INHIBITORS
Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors. Jedinjenja formule (I) i njihove farmaceutski prihvatljive soli, gde jeda...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
15.11.2002
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.
Jedinjenja formule (I) i njihove farmaceutski prihvatljive soli, gde jedan od R1 i R2 je H a drugi je N=C(NH2)2 a drugi supstituenti se kao što je definisano u opisu su urokinazni (uPA) inhibitori.[Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors. |
|---|---|
| AbstractList | Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.
Jedinjenja formule (I) i njihove farmaceutski prihvatljive soli, gde jedan od R1 i R2 je H a drugi je N=C(NH2)2 a drugi supstituenti se kao što je definisano u opisu su urokinazni (uPA) inhibitori.[Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors. |
| Author | ROGER, PETER DICKINSON BARBER, CHRISTOPHER GORDON PAUL, VINCENT FISH |
| Author_xml | – fullname: BARBER, CHRISTOPHER GORDON – fullname: ROGER, PETER DICKINSON – fullname: PAUL, VINCENT FISH |
| BookMark | eNrjYmDJy89L5WRQ9Qz2Dwz19PP38fRzDVZwDFYIDfL39vRzDHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3Ayybq4hzh66qQX58anFBYnJqXmpJfGRoUaGhgYGjsaE5AGTxCPW |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | IZOHINOLINI KAO UROKINAZNI INHIBITORI |
| ExternalDocumentID | YU21100A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_YU21100A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:01:14 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_YU21100A3 |
| Notes | Application Number: YU20000000211 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021115&DB=EPODOC&CC=YU&NR=21100A |
| ParticipantIDs | epo_espacenet_YU21100A |
| PublicationCentury | 2000 |
| PublicationDate | 20021115 |
| PublicationDateYYYYMMDD | 2002-11-15 |
| PublicationDate_xml | – month: 11 year: 2002 text: 20021115 day: 15 |
| PublicationDecade | 2000 |
| PublicationYear | 2002 |
| RelatedCompanies | PFIZER INC |
| RelatedCompanies_xml | – name: PFIZER INC |
| Score | 2.5618677 |
| Snippet | Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N=C(NH2)2 or NHC(=NH)NH2, and the other... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | ISOQUINOLINES AS UROKINASE INHIBITORS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20021115&DB=EPODOC&locale=&CC=YU&NR=21100A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB1BQcANChVbUQ6Qm0VMVg4RyqoE0aRkQe2pSpxE4lIqGsTvM3Fb4AA3y5bGi_Q88-xZAK4lo2DFXdMQw1AlojBZJwWtNVJVlOmGXDUVd_kfRVqQK48TdbL2tuhiYXie0E-eHBERxRDvLb-vFz-PWC73rVzelq_Y9fbgZ6Yrbtgx0hmqiq5teuPYjR3RccxpLkaJ2fEcydqGHTSh9Q4J3ovdRaQsfqsT_xB2xyhp3h7BVj3vw76zqbrWh73R-rMbm2vcLY_hJkzj5zyM4qeuSIZgpUKexEi8rdQTwigI7TCLk_QEhr6XOQHB-WbfG5tN89Wy5AH0kOzXpyBUjVoqpXyPPIYqhWYUSpcirtQY2v1Gw-gZDP6Wcf7fwAUcrCqYUELVS-i17x_1EBVpW17xU_gCNfp1YQ |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB1BQZQbFCq2Qg6QW0RMVg4RyqoEmqRkQe0pyipxKRUN4veZuC1wgJtlS-NFep559iwA17yal_ld03CqKvGcWAoKl5Na5qqKlIoqVE1FXf79QHZT8XEqTdfeFl0sDM0T-kmTIyKiSsR7S-_rxc8jlkV9K5e3xSt2vT04iWaxG3aMdIZIrGVo9iS0QpM1TW2WskGkdTyH17dhB81rpUOC_WJ0ESmL3-rEOYDdCUqat4ewVc8H0Dc3VdcGsOevP7uxucbd8ghuvDh8Tr0gHHdFMhg9ZtIoROKtxzbjBa5neEkYxccwcuzEdDmcL_veWDZLV8sShtBDsl-fAFM1UiEWwj3yGCLmspqLXYq4Qi7R7lebkpzC8G8ZZ_8NXEHfTfxxhgt8Oof9VTUTwhHpAnrt-0c9QqXaFpf0RL4A4cV4VA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ISOQUINOLINES+AS+UROKINASE+INHIBITORS&rft.inventor=BARBER%2C+CHRISTOPHER+GORDON&rft.inventor=ROGER%2C+PETER+DICKINSON&rft.inventor=PAUL%2C+VINCENT+FISH&rft.date=2002-11-15&rft.externalDBID=A&rft.externalDocID=YU21100A |